Drugs / Fomivirsen
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Withdrawn | EU (EMA) | Vitravene | — | 2002-07-30 | europa.eu ↗ |
| Approved | EU (EMA) | Vitravene | — | 1999-07-29 | europa.eu ↗ |
| Approved | US (FDA) | VITRAVENE PRESERVATIVE FREE | — | 1998-08-26 | fda.gov ↗ |
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00002156 | — | HIV infectious disease, cytomegalovirus retinitis | Ionis Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00002356 | — | HIV infectious disease, cytomegalovirus retinitis | Ionis Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT00002355 | — | HIV infectious disease, cytomegalovirus retinitis | Ionis Pharmaceuticals, Inc. | Completed | No outcome recorded |
| — | NCT00002187 | — | HIV infectious disease, cytomegalovirus retinitis | Ionis Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fomivirsen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002356 ↗ |
| Known as | Vitravene | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201688 ↗ |
| Route | Intravitreal | “intravitreal injections” NCT00002356 ↗ |